aluates Reports

$ 0.0

Automative

Global Amphotericin B Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-31N5684

Global Amphotericin B Market Insights and Forecast to 2028

BUY CHAPTERS

Global Amphotericin B Market Research Report 2025

Code: QYRE-Auto-31N5684

Report

September 2025

Pages:83

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bristol–Myers Squibb

Matinas BioPharma

Nanox

Nanomerics

DNDi

Abzena

Bharat Serums

Jina Pharma

Astellas Pharma

Leadiant Biosciences

Kadmon Corporation (Eli Lilly and Company)

InterMune

Sterimax

X-Gen Pharmaceuticals

Amphotericin B Market

The global market for Amphotericin B was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Amphotericin B shows a high order of in vitro activity against many species of fungi. Histoplasma capsulatum, Coccidioides immitis, Candida species, Blastomyces dermatitidis, Rhodotorula, Cryptococcus neoformans, Sporothrix schenckii, Mucor mucedo, and Aspergillus fumigatus are all inhibited by concentrations of amphotericin B ranging from 0.03 to 1.0 mcg/mL in vitro. While Candida albicans is generally quite susceptible to amphotericin B, non-albicans species may be less susceptible. Pseudallescheria boydii and Fusarium sp. are often resistant to amphotericin B. The antibiotic is without effect on bacteria, rickettsiae, and viruses.

North American market for Amphotericin B is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Amphotericin B is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Amphotericin B in Vaginitis is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Amphotericin B include Bristol-Myers Squibb, Matinas BioPharma, Nanox, Nanomerics, DNDi, Abzena, Bharat Serums, Jina Pharma, Astellas Pharma, Leadiant Biosciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Amphotericin B, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amphotericin B.

The Amphotericin B market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Amphotericin B market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Amphotericin B companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Amphotericin B Market Report

Report Metric	Details
Report Name	Amphotericin B Market
Segment by Type	Static Drops Atomization Inhalation Local Lesion Injection Other
Segment by Application	Vaginitis Candida Infection Leishmaniasis Kala-Azar Cryptococcal Infection Aspergillus Infection Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bristol-Myers Squibb, Matinas BioPharma, Nanox, Nanomerics, DNDi, Abzena, Bharat Serums, Jina Pharma, Astellas Pharma, Leadiant Biosciences, Kadmon Corporation (Eli Lilly and Company), InterMune, Sterimax Inc, X-GEN Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Amphotericin B company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Amphotericin B Market report?

Ans: The main players in the Amphotericin B Market are Bristol-Myers Squibb, Matinas BioPharma, Nanox, Nanomerics, DNDi, Abzena, Bharat Serums, Jina Pharma, Astellas Pharma, Leadiant Biosciences, Kadmon Corporation (Eli Lilly and Company), InterMune, Sterimax Inc, X-GEN Pharmaceuticals

What are the Application segmentation covered in the Amphotericin B Market report?

Ans: The Applications covered in the Amphotericin B Market report are Vaginitis, Candida Infection, Leishmaniasis, Kala-Azar, Cryptococcal Infection, Aspergillus Infection, Other

What are the Type segmentation covered in the Amphotericin B Market report?

Ans: The Types covered in the Amphotericin B Market report are Static Drops, Atomization Inhalation, Local Lesion Injection, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Amphotericin B Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Static Drops

1.2.3 Atomization Inhalation

1.2.4 Local Lesion Injection

1.2.5 Other

1.3 Market by Application

1.3.1 Global Amphotericin B Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Vaginitis

1.3.3 Candida Infection

1.3.4 Leishmaniasis

1.3.5 Kala-Azar

1.3.6 Cryptococcal Infection

1.3.7 Aspergillus Infection

1.3.8 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Amphotericin B Market Perspective (2020-2031)

2.2 Global Amphotericin B Growth Trends by Region

2.2.1 Global Amphotericin B Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Amphotericin B Historic Market Size by Region (2020-2025)

2.2.3 Amphotericin B Forecasted Market Size by Region (2026-2031)

2.3 Amphotericin B Market Dynamics

2.3.1 Amphotericin B Industry Trends

2.3.2 Amphotericin B Market Drivers

2.3.3 Amphotericin B Market Challenges

2.3.4 Amphotericin B Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Amphotericin B Players by Revenue

3.1.1 Global Top Amphotericin B Players by Revenue (2020-2025)

3.1.2 Global Amphotericin B Revenue Market Share by Players (2020-2025)

3.2 Global Amphotericin B Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Amphotericin B Revenue

3.4 Global Amphotericin B Market Concentration Ratio

3.4.1 Global Amphotericin B Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Amphotericin B Revenue in 2024

3.5 Global Key Players of Amphotericin B Head office and Area Served

3.6 Global Key Players of Amphotericin B, Product and Application

3.7 Global Key Players of Amphotericin B, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Amphotericin B Breakdown Data by Type

4.1 Global Amphotericin B Historic Market Size by Type (2020-2025)

4.2 Global Amphotericin B Forecasted Market Size by Type (2026-2031)

5 Amphotericin B Breakdown Data by Application

5.1 Global Amphotericin B Historic Market Size by Application (2020-2025)

5.2 Global Amphotericin B Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Amphotericin B Market Size (2020-2031)

6.2 North America Amphotericin B Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Amphotericin B Market Size by Country (2020-2025)

6.4 North America Amphotericin B Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Amphotericin B Market Size (2020-2031)

7.2 Europe Amphotericin B Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Amphotericin B Market Size by Country (2020-2025)

7.4 Europe Amphotericin B Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Amphotericin B Market Size (2020-2031)

8.2 Asia-Pacific Amphotericin B Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Amphotericin B Market Size by Region (2020-2025)

8.4 Asia-Pacific Amphotericin B Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Amphotericin B Market Size (2020-2031)

9.2 Latin America Amphotericin B Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Amphotericin B Market Size by Country (2020-2025)

9.4 Latin America Amphotericin B Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Amphotericin B Market Size (2020-2031)

10.2 Middle East & Africa Amphotericin B Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Amphotericin B Market Size by Country (2020-2025)

10.4 Middle East & Africa Amphotericin B Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bristol-Myers Squibb

11.1.1 Bristol-Myers Squibb Company Details

11.1.2 Bristol-Myers Squibb Business Overview

11.1.3 Bristol-Myers Squibb Amphotericin B Introduction

11.1.4 Bristol-Myers Squibb Revenue in Amphotericin B Business (2020-2025)

11.1.5 Bristol-Myers Squibb Recent Development

11.2 Matinas BioPharma

11.2.1 Matinas BioPharma Company Details

11.2.2 Matinas BioPharma Business Overview

11.2.3 Matinas BioPharma Amphotericin B Introduction

11.2.4 Matinas BioPharma Revenue in Amphotericin B Business (2020-2025)

11.2.5 Matinas BioPharma Recent Development

11.3 Nanox

11.3.1 Nanox Company Details

11.3.2 Nanox Business Overview

11.3.3 Nanox Amphotericin B Introduction

11.3.4 Nanox Revenue in Amphotericin B Business (2020-2025)

11.3.5 Nanox Recent Development

11.4 Nanomerics

11.4.1 Nanomerics Company Details

11.4.2 Nanomerics Business Overview

11.4.3 Nanomerics Amphotericin B Introduction

11.4.4 Nanomerics Revenue in Amphotericin B Business (2020-2025)

11.4.5 Nanomerics Recent Development

11.5 DNDi

11.5.1 DNDi Company Details

11.5.2 DNDi Business Overview

11.5.3 DNDi Amphotericin B Introduction

11.5.4 DNDi Revenue in Amphotericin B Business (2020-2025)

11.5.5 DNDi Recent Development

11.6 Abzena

11.6.1 Abzena Company Details

11.6.2 Abzena Business Overview

11.6.3 Abzena Amphotericin B Introduction

11.6.4 Abzena Revenue in Amphotericin B Business (2020-2025)

11.6.5 Abzena Recent Development

11.7 Bharat Serums

11.7.1 Bharat Serums Company Details

11.7.2 Bharat Serums Business Overview

11.7.3 Bharat Serums Amphotericin B Introduction

11.7.4 Bharat Serums Revenue in Amphotericin B Business (2020-2025)

11.7.5 Bharat Serums Recent Development

11.8 Jina Pharma

11.8.1 Jina Pharma Company Details

11.8.2 Jina Pharma Business Overview

11.8.3 Jina Pharma Amphotericin B Introduction

11.8.4 Jina Pharma Revenue in Amphotericin B Business (2020-2025)

11.8.5 Jina Pharma Recent Development

11.9 Astellas Pharma

11.9.1 Astellas Pharma Company Details

11.9.2 Astellas Pharma Business Overview

11.9.3 Astellas Pharma Amphotericin B Introduction

11.9.4 Astellas Pharma Revenue in Amphotericin B Business (2020-2025)

11.9.5 Astellas Pharma Recent Development

11.10 Leadiant Biosciences

11.10.1 Leadiant Biosciences Company Details

11.10.2 Leadiant Biosciences Business Overview

11.10.3 Leadiant Biosciences Amphotericin B Introduction

11.10.4 Leadiant Biosciences Revenue in Amphotericin B Business (2020-2025)

11.10.5 Leadiant Biosciences Recent Development

11.11 Kadmon Corporation (Eli Lilly and Company)

11.11.1 Kadmon Corporation (Eli Lilly and Company) Company Details

11.11.2 Kadmon Corporation (Eli Lilly and Company) Business Overview

11.11.3 Kadmon Corporation (Eli Lilly and Company) Amphotericin B Introduction

11.11.4 Kadmon Corporation (Eli Lilly and Company) Revenue in Amphotericin B Business (2020-2025)

11.11.5 Kadmon Corporation (Eli Lilly and Company) Recent Development

11.12 InterMune

11.12.1 InterMune Company Details

11.12.2 InterMune Business Overview

11.12.3 InterMune Amphotericin B Introduction

11.12.4 InterMune Revenue in Amphotericin B Business (2020-2025)

11.12.5 InterMune Recent Development

11.13 Sterimax Inc

11.13.1 Sterimax Inc Company Details

11.13.2 Sterimax Inc Business Overview

11.13.3 Sterimax Inc Amphotericin B Introduction

11.13.4 Sterimax Inc Revenue in Amphotericin B Business (2020-2025)

11.13.5 Sterimax Inc Recent Development

11.14 X-GEN Pharmaceuticals

11.14.1 X-GEN Pharmaceuticals Company Details

11.14.2 X-GEN Pharmaceuticals Business Overview

11.14.3 X-GEN Pharmaceuticals Amphotericin B Introduction

11.14.4 X-GEN Pharmaceuticals Revenue in Amphotericin B Business (2020-2025)

11.14.5 X-GEN Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Bristol–Myers Squibb

Matinas BioPharma

Nanox

Nanomerics

DNDi

Abzena

Bharat Serums

Jina Pharma

Astellas Pharma

Leadiant Biosciences

Kadmon Corporation (Eli Lilly and Company)

InterMune

Sterimax

X-Gen Pharmaceuticals

List of Tables

Table 1. Global Amphotericin B Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Static Drops

Table 3. Key Players of Atomization Inhalation

Table 4. Key Players of Local Lesion Injection

Table 5. Key Players of Other

Table 6. Global Amphotericin B Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Amphotericin B Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Amphotericin B Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Amphotericin B Market Share by Region (2020-2025)

Table 10. Global Amphotericin B Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Amphotericin B Market Share by Region (2026-2031)

Table 12. Amphotericin B Market Trends

Table 13. Amphotericin B Market Drivers

Table 14. Amphotericin B Market Challenges

Table 15. Amphotericin B Market Restraints

Table 16. Global Amphotericin B Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Amphotericin B Market Share by Players (2020-2025)

Table 18. Global Top Amphotericin B Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amphotericin B as of 2024)

Table 19. Ranking of Global Top Amphotericin B Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Amphotericin B Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Amphotericin B, Headquarters and Area Served

Table 22. Global Key Players of Amphotericin B, Product and Application

Table 23. Global Key Players of Amphotericin B, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Amphotericin B Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Amphotericin B Revenue Market Share by Type (2020-2025)

Table 27. Global Amphotericin B Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Amphotericin B Revenue Market Share by Type (2026-2031)

Table 29. Global Amphotericin B Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Amphotericin B Revenue Market Share by Application (2020-2025)

Table 31. Global Amphotericin B Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Amphotericin B Revenue Market Share by Application (2026-2031)

Table 33. North America Amphotericin B Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Amphotericin B Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Amphotericin B Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Amphotericin B Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Amphotericin B Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Amphotericin B Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Amphotericin B Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Amphotericin B Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Amphotericin B Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Amphotericin B Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Amphotericin B Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Amphotericin B Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Amphotericin B Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Amphotericin B Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Amphotericin B Market Size by Country (2026-2031) & (US$ Million)

Table 48. Bristol-Myers Squibb Company Details

Table 49. Bristol-Myers Squibb Business Overview

Table 50. Bristol-Myers Squibb Amphotericin B Product

Table 51. Bristol-Myers Squibb Revenue in Amphotericin B Business (2020-2025) & (US$ Million)

Table 52. Bristol-Myers Squibb Recent Development

Table 53. Matinas BioPharma Company Details

Table 54. Matinas BioPharma Business Overview

Table 55. Matinas BioPharma Amphotericin B Product

Table 56. Matinas BioPharma Revenue in Amphotericin B Business (2020-2025) & (US$ Million)

Table 57. Matinas BioPharma Recent Development

Table 58. Nanox Company Details

Table 59. Nanox Business Overview

Table 60. Nanox Amphotericin B Product

Table 61. Nanox Revenue in Amphotericin B Business (2020-2025) & (US$ Million)

Table 62. Nanox Recent Development

Table 63. Nanomerics Company Details

Table 64. Nanomerics Business Overview

Table 65. Nanomerics Amphotericin B Product

Table 66. Nanomerics Revenue in Amphotericin B Business (2020-2025) & (US$ Million)

Table 67. Nanomerics Recent Development

Table 68. DNDi Company Details

Table 69. DNDi Business Overview

Table 70. DNDi Amphotericin B Product

Table 71. DNDi Revenue in Amphotericin B Business (2020-2025) & (US$ Million)

Table 72. DNDi Recent Development

Table 73. Abzena Company Details

Table 74. Abzena Business Overview

Table 75. Abzena Amphotericin B Product

Table 76. Abzena Revenue in Amphotericin B Business (2020-2025) & (US$ Million)

Table 77. Abzena Recent Development

Table 78. Bharat Serums Company Details

Table 79. Bharat Serums Business Overview

Table 80. Bharat Serums Amphotericin B Product

Table 81. Bharat Serums Revenue in Amphotericin B Business (2020-2025) & (US$ Million)

Table 82. Bharat Serums Recent Development

Table 83. Jina Pharma Company Details

Table 84. Jina Pharma Business Overview

Table 85. Jina Pharma Amphotericin B Product

Table 86. Jina Pharma Revenue in Amphotericin B Business (2020-2025) & (US$ Million)

Table 87. Jina Pharma Recent Development

Table 88. Astellas Pharma Company Details

Table 89. Astellas Pharma Business Overview

Table 90. Astellas Pharma Amphotericin B Product

Table 91. Astellas Pharma Revenue in Amphotericin B Business (2020-2025) & (US$ Million)

Table 92. Astellas Pharma Recent Development

Table 93. Leadiant Biosciences Company Details

Table 94. Leadiant Biosciences Business Overview

Table 95. Leadiant Biosciences Amphotericin B Product

Table 96. Leadiant Biosciences Revenue in Amphotericin B Business (2020-2025) & (US$ Million)

Table 97. Leadiant Biosciences Recent Development

Table 98. Kadmon Corporation (Eli Lilly and Company) Company Details

Table 99. Kadmon Corporation (Eli Lilly and Company) Business Overview

Table 100. Kadmon Corporation (Eli Lilly and Company) Amphotericin B Product

Table 101. Kadmon Corporation (Eli Lilly and Company) Revenue in Amphotericin B Business (2020-2025) & (US$ Million)

Table 102. Kadmon Corporation (Eli Lilly and Company) Recent Development

Table 103. InterMune Company Details

Table 104. InterMune Business Overview

Table 105. InterMune Amphotericin B Product

Table 106. InterMune Revenue in Amphotericin B Business (2020-2025) & (US$ Million)

Table 107. InterMune Recent Development

Table 108. Sterimax Inc Company Details

Table 109. Sterimax Inc Business Overview

Table 110. Sterimax Inc Amphotericin B Product

Table 111. Sterimax Inc Revenue in Amphotericin B Business (2020-2025) & (US$ Million)

Table 112. Sterimax Inc Recent Development

Table 113. X-GEN Pharmaceuticals Company Details

Table 114. X-GEN Pharmaceuticals Business Overview

Table 115. X-GEN Pharmaceuticals Amphotericin B Product

Table 116. X-GEN Pharmaceuticals Revenue in Amphotericin B Business (2020-2025) & (US$ Million)

Table 117. X-GEN Pharmaceuticals Recent Development

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Amphotericin B Picture

Figure 2. Global Amphotericin B Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Amphotericin B Market Share by Type: 2024 VS 2031

Figure 4. Static Drops Features

Figure 5. Atomization Inhalation Features

Figure 6. Local Lesion Injection Features

Figure 7. Other Features

Figure 8. Global Amphotericin B Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Amphotericin B Market Share by Application: 2024 VS 2031

Figure 10. Vaginitis Case Studies

Figure 11. Candida Infection Case Studies

Figure 12. Leishmaniasis Case Studies

Figure 13. Kala-Azar Case Studies

Figure 14. Cryptococcal Infection Case Studies

Figure 15. Aspergillus Infection Case Studies

Figure 16. Other Case Studies

Figure 17. Amphotericin B Report Years Considered

Figure 18. Global Amphotericin B Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 19. Global Amphotericin B Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 20. Global Amphotericin B Market Share by Region: 2024 VS 2031

Figure 21. Global Amphotericin B Market Share by Players in 2024

Figure 22. Global Top Amphotericin B Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amphotericin B as of 2024)

Figure 23. The Top 10 and 5 Players Market Share by Amphotericin B Revenue in 2024

Figure 24. North America Amphotericin B Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. North America Amphotericin B Market Share by Country (2020-2031)

Figure 26. United States Amphotericin B Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Canada Amphotericin B Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Amphotericin B Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Europe Amphotericin B Market Share by Country (2020-2031)

Figure 30. Germany Amphotericin B Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. France Amphotericin B Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. U.K. Amphotericin B Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Italy Amphotericin B Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Russia Amphotericin B Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Nordic Countries Amphotericin B Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Amphotericin B Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific Amphotericin B Market Share by Region (2020-2031)

Figure 38. China Amphotericin B Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Japan Amphotericin B Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. South Korea Amphotericin B Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Amphotericin B Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. India Amphotericin B Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Australia Amphotericin B Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Amphotericin B Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Latin America Amphotericin B Market Share by Country (2020-2031)

Figure 46. Mexico Amphotericin B Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Brazil Amphotericin B Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Amphotericin B Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Middle East & Africa Amphotericin B Market Share by Country (2020-2031)

Figure 50. Turkey Amphotericin B Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Amphotericin B Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. UAE Amphotericin B Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Bristol-Myers Squibb Revenue Growth Rate in Amphotericin B Business (2020-2025)

Figure 54. Matinas BioPharma Revenue Growth Rate in Amphotericin B Business (2020-2025)

Figure 55. Nanox Revenue Growth Rate in Amphotericin B Business (2020-2025)

Figure 56. Nanomerics Revenue Growth Rate in Amphotericin B Business (2020-2025)

Figure 57. DNDi Revenue Growth Rate in Amphotericin B Business (2020-2025)

Figure 58. Abzena Revenue Growth Rate in Amphotericin B Business (2020-2025)

Figure 59. Bharat Serums Revenue Growth Rate in Amphotericin B Business (2020-2025)

Figure 60. Jina Pharma Revenue Growth Rate in Amphotericin B Business (2020-2025)

Figure 61. Astellas Pharma Revenue Growth Rate in Amphotericin B Business (2020-2025)

Figure 62. Leadiant Biosciences Revenue Growth Rate in Amphotericin B Business (2020-2025)

Figure 63. Kadmon Corporation (Eli Lilly and Company) Revenue Growth Rate in Amphotericin B Business (2020-2025)

Figure 64. InterMune Revenue Growth Rate in Amphotericin B Business (2020-2025)

Figure 65. Sterimax Inc Revenue Growth Rate in Amphotericin B Business (2020-2025)

Figure 66. X-GEN Pharmaceuticals Revenue Growth Rate in Amphotericin B Business (2020-2025)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Amphotericin B Liposome for Injection Market Research Report 2024

Global Fungal Susceptibility Test Kit Market Research Report 2024

Global Sporothrix Schenckii Infection Treatment Market Research Report 2024

Global Itraconazole Inhibitors Market Research Report 2024

Global Mucormycosis Treatment Drugs Market Research Report 2025

Global Fluconazole Preparation Market Research Report 2024

Liposomal Amphoteracin B Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antifungal Susceptibility Testing Market Research Report 2024

Global Anti microbial and Anti fungal Tests Market Research Report 2024

Global Fungal Keratitis Medicine Market Research Report 2024

Candida Infections Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Echinocandins Market Research Report 2024

Amphotericin B API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

AmBisome Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti fungal Tests Market Research Report 2024

Microbial Fungicides Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti Fungal Agents Market Insights Forecast to 2030

Global Drugs for Vulvovaginal Candidiasis Market Research Report 2025

Global Antimicrobial Susceptibility Tester Market Insights Forecast to 2030

RELATED REPORTS

Global Geriatric Care Services Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-17Q6174

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Hospice Software Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8Z4276

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Geriatric Care Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8Q8325

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Allied Health Care Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29V19536

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions